TREATMENT WITH RUXOLITINIB IN COMBINATION WITH EXTRACORPOREAL PHOTOPHERESIS IN STEROID-REFRACTORY ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A SINGLE-CENTRE REAL-WORLD EXPERIENCE

被引:0
|
作者
Wais, Verena [1 ]
Gantner, Andrea [1 ]
Weidt, Conrad [1 ]
Neagoie, Adela [1 ]
Schnell, Jacqueline [1 ]
Doehner, Hartmut [1 ]
Bunjes, Donald [1 ]
Sala, Elisa [1 ]
机构
[1] Univ Hosp Ulm, Ulm, Germany
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P212
引用
收藏
页码:297 / 297
页数:1
相关论文
共 50 条
  • [1] A single-centre experience of the efficacy of extracorporeal photopheresis in the treatment of steroid-refractory acute graft-versus-host disease
    Das-Gupta, E.
    Watson, L.
    Byrne, J.
    Russell, N.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S114 - S114
  • [2] Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease
    Murray, Alistair
    Linn, Swe Mar
    Yu, Benoit
    Novitzky-Basso, Igor
    Mattsson, Jonas
    Kennah, Michael
    Elemary, Mohamed
    White, Jennifer
    Lemieux, Christopher
    Jamani, Kareem
    Kim, Dennis Dong Hwan
    [J]. BONE MARROW TRANSPLANTATION, 2024, 59 (06) : 759 - 764
  • [3] Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience
    Spalek, Adrianna
    Wieczorkiewicz-Kabut, Agata
    Koclega, Anna
    Wozniczka, Krzysztof
    Weglarz, Patryk
    Boral, Kinga
    Kata, Dariusz
    Zielinska, Patrycja
    Helbig, Grzegorz
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (06) : 922 - 928
  • [4] Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience
    Adrianna Spałek
    Agata Wieczorkiewicz-Kabut
    Anna Koclęga
    Krzysztof Woźniczka
    Patryk Węglarz
    Kinga Boral
    Dariusz Kata
    Patrycja Zielińska
    Grzegorz Helbig
    [J]. International Journal of Hematology, 2022, 116 : 922 - 928
  • [5] Extracorporeal photopheresis in treatment of refractory graft-versus-host disease: a single-centre experience
    Chui, S. Q.
    Kassim, F.
    Othman, N.
    Guan, Y. K.
    Ong, T. C.
    Chang, K. M.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S348 - S348
  • [6] Experience with the Use of Infliximab and/or Extracorporeal Photopheresis in Steroid-Refractory Acute Graft Versus Host Disease
    Nygaard, Marietta
    Karlsmark, Tonny
    Smedegaard, Niels
    Schjodt, Ida
    Friis, Lone S.
    Petersen, Soren
    Komblit, Brian
    Sengelov, Henrik
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S194 - S195
  • [7] A single centre experience of ruxolitinib for treatment of steroid refractory chronic graft versus host disease
    Kirkham, Z.
    Ethell, M.
    Potter, M.
    Arias, C. Gonzalez
    Davis, K.
    Dallas, F.
    Salmen, C.
    Anthias, C.
    Nicholson, E.
    Easdale, S.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 215 - 215
  • [8] Real-world data on ruxolitinib in steroid-refractory acute intestinal graft-versus-host-disease
    Biavasco, F.
    Ihorst, G.
    Waesch, R.
    Wehr, C.
    Bertz, H.
    Finke, J.
    Zeiser, R.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 184 - 185
  • [9] Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience
    Xue, Elisabetta
    Lorentino, Francesca
    Pavesi, Francesca
    Assanelli, Andrea
    Peccatori, Jacopo
    Bernardi, Massimo
    Corti, Consuelo
    Ciceri, Fabio
    Stanghellini, Maria Teresa Lupo
    [J]. LEUKEMIA RESEARCH, 2021, 109
  • [10] Real-World Experience with Ruxolitinib Therapy for Steroid Refractory Acute Graft Versus Host Disease
    Murray, Alistair
    Linn, Swe Mar
    Yu, Benoit
    Novitzky-Basso, Igor
    Mattsson, Jonas
    Elemary, Mohamed
    White, Jennifer
    Lemieux, Christopher
    Jamani, Kareem
    Kim, Dennis
    [J]. BLOOD, 2022, 140 : 7662 - 7663